Rural Health
Resources by Topic: Pharmacy and prescription drugs
Generic Drug Utilization and Spending Among Medicare Part D Enrollees in 2022
Issue brief on prescriptions for generic drugs filled by Medicare Part D enrollees using 2022 Part D prescription drug event (PDE) data. Covers commonly used prescription drugs, costs, and conditions treated, and includes data breakdowns by plan type, race and ethnicity, and level of rurality throughout. Discusses formulary design to improve access by promoting affordability and reducing confusion among enrollees.
Author(s): Yevgeniy Feyman, Bisma Sayed, Kenneth Finegold, et al.
Date: 03/2024
Sponsoring organization: HHS Office of the Assistant Secretary for Planning and Evaluation
view details
Issue brief on prescriptions for generic drugs filled by Medicare Part D enrollees using 2022 Part D prescription drug event (PDE) data. Covers commonly used prescription drugs, costs, and conditions treated, and includes data breakdowns by plan type, race and ethnicity, and level of rurality throughout. Discusses formulary design to improve access by promoting affordability and reducing confusion among enrollees.
Author(s): Yevgeniy Feyman, Bisma Sayed, Kenneth Finegold, et al.
Date: 03/2024
Sponsoring organization: HHS Office of the Assistant Secretary for Planning and Evaluation
view details
Inflation Reduction Act Research Series: Projected Impacts for Rural Medicare Enrollees
Provides an overview of how the Inflation Reduction Act (IRA) is intended to improve prescription drug affordability for Medicare enrollees. Describes Medicare enrollment in rural areas and rural residents' health status and access to care. Outlines the projected impact of drug-related IRA provisions for rural Medicare beneficiaries, including the expansion of financial assistance through the low-income subsidy program, out-of-pocket spending caps for insulin, changes in Part D benefit design, and more.
Date: 03/2024
Sponsoring organization: HHS Office of the Assistant Secretary for Planning and Evaluation
view details
Provides an overview of how the Inflation Reduction Act (IRA) is intended to improve prescription drug affordability for Medicare enrollees. Describes Medicare enrollment in rural areas and rural residents' health status and access to care. Outlines the projected impact of drug-related IRA provisions for rural Medicare beneficiaries, including the expansion of financial assistance through the low-income subsidy program, out-of-pocket spending caps for insulin, changes in Part D benefit design, and more.
Date: 03/2024
Sponsoring organization: HHS Office of the Assistant Secretary for Planning and Evaluation
view details
What Does Pharmacy Access Look like in Your Area?
Interactive map showing the number of pharmacies and pharmacies per 1,000 people at the state and county level. Includes the option to view race and ethnicity data at the county level for Black, Hispanic, and White residents.
Date: 02/2024
Sponsoring organization: The Associated Press
view details
Interactive map showing the number of pharmacies and pharmacies per 1,000 people at the state and county level. Includes the option to view race and ethnicity data at the county level for Black, Hispanic, and White residents.
Date: 02/2024
Sponsoring organization: The Associated Press
view details
Telemedicine vs Telephone Consultations and Medication Prescribing Errors Among Referring Physicians: A Cluster Randomized Crossover Trial
Compared 696 acutely ill children in 15 community and rural California emergency departments receiving telephone or video consultations to determine differences in physician-related medication errors. Discusses the impact of telehealth on healthcare quality and remote acute care.
Author(s): James P. Marcin, Monica K. Lieng, Jamie Mouzoon, et al.
Citation: JAMA Network Open, 7(2)
Date: 02/2024
view details
Compared 696 acutely ill children in 15 community and rural California emergency departments receiving telephone or video consultations to determine differences in physician-related medication errors. Discusses the impact of telehealth on healthcare quality and remote acute care.
Author(s): James P. Marcin, Monica K. Lieng, Jamie Mouzoon, et al.
Citation: JAMA Network Open, 7(2)
Date: 02/2024
view details
Hearing on Examining Chronic Drug Shortages in the United States
Congressional hearing in the U.S. House of Representatives Ways & Means Committee discussing pharmaceutical drug shortages. Discusses cancer care, healthcare quality, the 340B program, supply and demand, reimbursement, and other policy measures. Witnesses include Dr. Stephen Schleicher discussing rural concerns. Captions available in video player.
Additional links: Dr. Stephen Schleicher Testimony
Date: 02/2024
Sponsoring organization: House Ways and Means Committee
view details
Congressional hearing in the U.S. House of Representatives Ways & Means Committee discussing pharmaceutical drug shortages. Discusses cancer care, healthcare quality, the 340B program, supply and demand, reimbursement, and other policy measures. Witnesses include Dr. Stephen Schleicher discussing rural concerns. Captions available in video player.
Additional links: Dr. Stephen Schleicher Testimony
Date: 02/2024
Sponsoring organization: House Ways and Means Committee
view details
Testing the Feasibility of the QuitAid Smoking Cessation Intervention in a Randomized Factorial Design in an Independent, Rural Community Pharmacy
Examines a pharmacist-delivered smoking cessation intervention in rural Appalachia. Analyzes an ask-advise-connect model conducted with 24 adult smokers between September and November 2021, observing recruitment, retention, treatment adherence, and fidelity. Includes data on participant demographics, participant satisfaction, and pharmacist perceptions.
Author(s): Melissa A. Little, Taylor Reid, Matthew Moncrief, et al.
Citation: Pilot and Feasibility Studies, 10(41)
Date: 02/2024
view details
Examines a pharmacist-delivered smoking cessation intervention in rural Appalachia. Analyzes an ask-advise-connect model conducted with 24 adult smokers between September and November 2021, observing recruitment, retention, treatment adherence, and fidelity. Includes data on participant demographics, participant satisfaction, and pharmacist perceptions.
Author(s): Melissa A. Little, Taylor Reid, Matthew Moncrief, et al.
Citation: Pilot and Feasibility Studies, 10(41)
Date: 02/2024
view details
Beneficiary and Clinician Perspectives on Medicare and Other Issues: Findings from 2023 Focus Groups in Select States
Summarizes findings from 24 focus groups of Medicare beneficiaries, Medicare and Medicaid (dual eligible) beneficiaries, and clinicians conducted between May and July 2023, including three virtual focus groups of rural Medicare beneficiaries. Highlights themes that emerged across the focus groups covering Medicare coverage options, access to care, telehealth, organization of care, and prescription drugs.
Date: 02/2024
Sponsoring organizations: Medicare Payment Advisory Commission, NORC at the University of Chicago
view details
Summarizes findings from 24 focus groups of Medicare beneficiaries, Medicare and Medicaid (dual eligible) beneficiaries, and clinicians conducted between May and July 2023, including three virtual focus groups of rural Medicare beneficiaries. Highlights themes that emerged across the focus groups covering Medicare coverage options, access to care, telehealth, organization of care, and prescription drugs.
Date: 02/2024
Sponsoring organizations: Medicare Payment Advisory Commission, NORC at the University of Chicago
view details
2024 Rural Advocacy Agenda
Outlines the American Hospital Association's federal policy priorities for rural hospitals in 2024. Offers recommendations in the areas of commercial insurer accountability, flexible payment options, reimbursement, workforce, and the 340B program.
Date: 02/2024
Sponsoring organization: American Hospital Association
view details
Outlines the American Hospital Association's federal policy priorities for rural hospitals in 2024. Offers recommendations in the areas of commercial insurer accountability, flexible payment options, reimbursement, workforce, and the 340B program.
Date: 02/2024
Sponsoring organization: American Hospital Association
view details
Medicare Enrollees and the Part D Drug Benefit: Improving Financial Protection through the Low- Income Subsidy
Provides an overview of the Medicare Part D Low-Income Subsidy (LIS) program, which covers some or all Part D drug costs. Presents estimates of number of Medicare Part D enrollees who received LIS in 2020 and their characteristics, as well as Medicare beneficiaries who did and did not have prescription drug coverage but who appear to be eligible for LIS based on income and resources. Compares Medicare enrollees demographic, financial, health status, and healthcare utilization characteristics, including rurality.
Author(s): Yevgeniy Feyman, Joel Ruhter, Kenneth Finegold, et al.
Date: 02/2024
Sponsoring organization: HHS Office of the Assistant Secretary for Planning and Evaluation
view details
Provides an overview of the Medicare Part D Low-Income Subsidy (LIS) program, which covers some or all Part D drug costs. Presents estimates of number of Medicare Part D enrollees who received LIS in 2020 and their characteristics, as well as Medicare beneficiaries who did and did not have prescription drug coverage but who appear to be eligible for LIS based on income and resources. Compares Medicare enrollees demographic, financial, health status, and healthcare utilization characteristics, including rurality.
Author(s): Yevgeniy Feyman, Joel Ruhter, Kenneth Finegold, et al.
Date: 02/2024
Sponsoring organization: HHS Office of the Assistant Secretary for Planning and Evaluation
view details
Geographic Variation and Racial Disparities in Adoption of Newer Glucose-Lowering Drugs with Cardiovascular Benefits among US Medicare Beneficiaries with Type 2 Diabetes
Analyzes the use of glucose-lowering drugs (GLDs) among people with type 2 diabetes, utilizing 2017-2018 Medicare Part D beneficiary claims data. Identifies rural-urban and racial disparities in GLD initiation rates, and discusses factors influencing equitable access to cardiovascular treatment.
Author(s): Wei-Han Chen, Yujia Li, Lanting Yang, et al.
Citation: Plos ONE, 19(1), e0297208
Date: 01/2024
view details
Analyzes the use of glucose-lowering drugs (GLDs) among people with type 2 diabetes, utilizing 2017-2018 Medicare Part D beneficiary claims data. Identifies rural-urban and racial disparities in GLD initiation rates, and discusses factors influencing equitable access to cardiovascular treatment.
Author(s): Wei-Han Chen, Yujia Li, Lanting Yang, et al.
Citation: Plos ONE, 19(1), e0297208
Date: 01/2024
view details